Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection

Bosserman, Rachel E.; Farnsworth, Christopher W.; O’Neil, Caroline A.; Cass, Candice, Park, Daniel, Ballman, Claire, Wallace, Meghan A.; Struttmann, Emily, Stewart, Henry, Arter, Olivia, Peacock, Kate, Fraser, Victoria J.; Budge, Philip J.; Olsen, Margaret A.; Burnham, Carey-Ann D.; Babcock, Hilary M.; Kwon, Jennie H.

Bosserman, Rachel E.; Farnsworth, Christopher W.; O’Neil, Caroline A.; Cass, Candice, Park, Daniel, Ballman, Claire, Wallace, Meghan A.; Struttmann, Emily, Stewart, Henry, Arter, Olivia, Peacock, Kate, Fraser, Victoria J.; Budge, Philip J.; Olsen, Margaret A.; Burnham, Carey-Ann D.; Babcock, Hilary M.; Kwon, Jennie H..

Antimicrobial stewardship & healthcare epidemiology : ASHE ; 2(1), 2022.

Article in English | EuropePMC | ID: covidwho-2147131

ABSTRACT

ABSTRACT

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14–28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70–180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Language: English Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML